This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: National Cancer Center, Protanbio Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 264 
1 out of 1 Years Active: 2025-2026
Title: Sangjin Lee: Innovator in Oncolytic Virus Research
Introduction
Sangjin Lee is a prominent inventor based in Paju-si, South Korea. He has made significant contributions to the field of oncolytic virus research, focusing on enhancing virus activity and production. His innovative work is crucial in the ongoing battle against cancer.
Latest Patents
Sangjin Lee holds a patent for a composition comprising NC886 aimed at improving oncolytic virus activity or production. The present invention relates to a composition for enhancing oncolytic virus activity which comprises NC886, and a composition for enhancing virus production which comprises the same. This patent highlights his commitment to advancing cancer treatment methodologies.
Career Highlights
Sangjin Lee is affiliated with the National Cancer Center, where he conducts research that bridges the gap between scientific discovery and clinical application. His work is instrumental in developing new therapeutic strategies for cancer patients.
Collaborations
Some of his notable coworkers include Yongsun Lee and Inhoo Kim, who collaborate with him on various research projects aimed at improving cancer therapies.
Conclusion
Sangjin Lee's innovative contributions to oncolytic virus research exemplify the potential of scientific advancements in cancer treatment. His work continues to inspire future research in this vital area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile